Literature DB >> 16619537

Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells.

Meenakshi Kuhar1, Sudip Sen, Neeta Singh.   

Abstract

Dietary phytochemicals have been shown to be chemopreventive against various types of cancer. This study was designed to investigate the enhancement of the chemoresponse to cisplatin by quercetin in human lung cancer H-520 cells and to elucidate the role of mitochondria in the induction of apoptosis. Apoptosis was detected by flow cytometry. The protein expressions of Bcl-XL, Bcl-2, Bax, cytochrome c and AIF were studied by Western blotting. The transcription of antioxidant enzymes was quantitated by RT-PCR. The findings suggested that priming H-520 cells with quercetin increased the cisplatin-induced apoptosis by 30.2%. This was accompanied by down-regulation of Bcl-XL and Bcl-2 and up-regulation of Bax. Both cytochrome c and AIF were implicated in the apoptotic process. There was no significant change in the transcription level of antioxidant enzymes in quercetin-mediated apoptosis. Based on these findings, it can be concluded that quercetin might act as an effective chemosensitizer in the chemotherapy of lung cancer by regulating the expression of various apoptosis-related genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619537

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  Rational development of a cytotoxic peptide to trigger cell death.

Authors:  Rebecca J Boohaker; Ge Zhang; Michael W Lee; Kathleen N Nemec; Santimukul Santra; J Manuel Perez; Annette R Khaled
Journal:  Mol Pharm       Date:  2012-05-29       Impact factor: 4.939

2.  Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.

Authors:  Temesgen Samuel; Khalda Fadlalla; Lachundra Mosley; Venkat Katkoori; Timothy Turner; Upender Manne
Journal:  Anticancer Res       Date:  2012-01       Impact factor: 2.480

3.  Induction of apoptosis by hydrogen peroxide in HPV 16 positive human cervical cancer cells: involvement of mitochondrial pathway.

Authors:  Mayank Singh; Neeta Singh
Journal:  Mol Cell Biochem       Date:  2007-11-29       Impact factor: 3.396

Review 4.  Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals.

Authors:  Chuan Li; Jia Zhang; Yu-Jiao Zu; Shu-Fang Nie; Jun Cao; Qian Wang; Shao-Ping Nie; Ze-Yuan Deng; Ming-Yong Xie; Shu Wang
Journal:  Chin J Nat Med       Date:  2015-09

5.  Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib.

Authors:  Feng-Ting Liu; Samir G Agrawal; Zanyar Movasaghi; Peter B Wyatt; Ihtesham U Rehman; John G Gribben; Adrian C Newland; Li Jia
Journal:  Blood       Date:  2008-07-16       Impact factor: 22.113

6.  Diepoxybutane activates the mitochondrial apoptotic pathway and mediates apoptosis in human lymphoblasts through oxidative stress.

Authors:  Sridevi Yadavilli; Eduardo Martinez-Ceballos; Janana Snowden-Aikens; Angela Hurst; Tranole Joseph; Thomas Albrecht; Perpetua M Muganda
Journal:  Toxicol In Vitro       Date:  2007-06-28       Impact factor: 3.500

7.  Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cells.

Authors:  Muzafar A Macha; Ajay Matta; Shyam Singh Chauhan; K W Michael Siu; Ranju Ralhan
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

8.  14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells.

Authors:  Muzafar A Macha; Ajay Matta; Ss Chauhan; Kw Michael Siu; Ranju Ralhan
Journal:  BMC Cancer       Date:  2010-11-30       Impact factor: 4.430

9.  Flavonoids in prevention of diseases with respect to modulation of Ca-pump function.

Authors:  Lubica Horáková
Journal:  Interdiscip Toxicol       Date:  2011-09

10.  Antioxidant intervention of smoking-induced lung tumor in mice by vitamin E and quercetin.

Authors:  Jie Yang; Lu Wang; Zhaoli Chen; Zhi-Qiang Shen; Min Jin; Xin-Wei Wang; Yufei Zheng; Zhi-Gang Qiu; Jing-Feng Wang; Jun-Wen Li
Journal:  BMC Cancer       Date:  2008-12-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.